Will a Glaucoma Drug Revolutionize Androgenetic Alopecia Treatment? On Repurposing a Drug Whose Side Effect Became a Desired Therapy Outcome.

The article discusses the potential of latanoprost, a synthetic analog of prostaglandin F2α originally used to treat glaucoma, as a treatment for androgenetic alopecia. Latanoprost's side effect of excessive eyelash growth has led to interest in its active metabolite, latanoprost acid, as a promising alternative to minoxidil and finasteride, the only currently registered treatments for this type of hair loss. The development of hair loss treatments containing prostaglandin derivatives, including latanoprost acid, is expected to be faster than traditional drug development processes.